However, the possibility of cutaneous anergy in patients withunderlying autoimmune disease must also be considered.[15,18] A higherproportion of patients receiving TNF-α inhibitors experience extrapulmonary or disseminated tuberculosis compared with infections inthe general population, suggesting that this may be a class effect.[15,17,18]. Here, TNF is linked to infection.